H(1)-antihistamines are first line treatment of chronic urticaria, but many patients do not get satisfactory relief with recommended doses. European guidelines recommend increased antihistamine doses of up to 4-fold.
Desloratadine Glenmark 5 mg Tablets are indicated in adults and adolescents aged 12 years and older for the relief of symptoms associated with: - allergic rhinitis (See section 5.1) - urticaria (see section 5.1)
Neoclarityn is indicated in adults, adolescents and children over the age of 1 year for the relief of symptoms associated with: - allergic rhinitis (see section 5.1) - urticaria (see section 5.1)
Desloratadine is indicated in adults and adolescents aged 12 years or older for the relief of symptoms associated with: - allergic rhinitis (see section 5.1), - urticaria (see section 5.1).
Desloratadine Mylan is indicated in adults and adolescents aged 12 years and older for the relief of symptoms associated with: - allergic rhinitis (see section 5.1). - urticaria (see section 5.1).